文献速递功能神经外科

癫痫丘脑前核深部脑刺激的最佳靶点:一项Meta分析

Optimal targeting of the anterior nucleus of the thalamus for epilepsy: a meta-analysis.
PubMed 文献 · J Neurosurg · 2022-04-08

该系统评价与Meta分析检索并纳入7项研究共162例癫痫患者,分析丘脑前核深部脑刺激(ANT DBS)活性触点位置与疗效的关系;平均随访2.3年时56%患者为应答者,应答者活性触点较非应答者平均偏前1.6 mm(95% CI 1.5-1.6 mm,p < 0.001)且邻近乳头丘脑束(MTT),提示ANT内邻近MTT亚区刺激可能改善 outcome。

要点

  • 平均随访2.3年时56%患者为应答者(癫痫发作减少≥50%)。
  • 应答者活性触点较非应答者平均偏前1.6 mm(95% CI 1.5-1.6 mm,p < 0.001)。
  • 应答者活性触点邻近乳头丘脑束(MTT),提示该亚区刺激可能改善疗效。

核心结论

  • 精准靶向丘脑前核(ANT)对癫痫DBS的成功结局至关重要。
  • 这些发现提示,刺激ANT内邻近乳头丘脑束(MTT)的亚区可改善结局。

研究设计与样本

  • 系统评价与Meta分析,按PRISMA标准检索文献,纳入报告ANT DBS活性触点位置与结局的研究。
  • 共筛选555项研究,最终纳入7项研究、162例患者进行分析。
  • 队列平均癫痫病程23年,DBS前平均发作频率56次/月。
  • 5项研究(n=62,占队列38%)采用直接靶向植入DBS电极,4项研究(n=123,76%)经室间电极轨迹植入。

主要发现

  • 平均随访2.3年时,56%患者为应答者(定义为末次随访癫痫发作减少≥50%)。
  • 应答者活性触点较非应答者平均偏前1.6 mm(95% CI 1.5-1.6 mm,p < 0.001)。
  • 应答者活性触点邻近乳头丘脑束(MTT)。

关键数值与推荐

  • 应答者定义:末次随访癫痫发作减少≥50%。
  • 应答者活性触点较非应答者平均偏前1.6 mm(95% CI 1.5-1.6 mm,p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) has been shown to be an effective therapeutic option for select patients with limbic epilepsy. However, the optimal target and electrode position for this indication remains undefined. Therefore, the objective of this systematic review and meta-analysis is to quantify the association between active contact location and outcomes across all published series of ANT DBS. METHODS: A literature search using PRISMA criteria was performed to identify all studies that reported both active contact locations and outcomes of DBS in the ANT for epilepsy. Patient, disease, treatment, and outcome data were extracted for statistical analysis. Contact locations of responders (defined as ≥ 50% seizure reduction at last follow-up) versus nonresponders to DBS were analyzed on a common reference frame. Centers of mass, weighted by clinical response, were computed for the contacts in each cohort. RESULTS: From 555 studies that were screened for review, a total of 7 studies comprising 162 patients met criteria for inclusion and were analyzed. Across the cohort, the mean duration of epilepsy was 23 years and the mean pre-DBS seizure frequency was 56 seizures per month. DBS electrodes were implanted using direct targeting in 5 studies (n = 62, 38% of patient cohort) via a transventricular electrode trajectory in 4 studies (n = 123, 76%). At the mean follow-up duration of 2.3 years, 56% of patients were considered responders. Active contacts of responders were 1.6 mm anterior (95% CI 1.5-1.6 mm, p < 0.001) compared to those of nonresponders and were adjacent to the mammillothalamic tract (MTT). CONCLUSIONS: Accurate targeting of the ANT is crucial to successful DBS outcomes in epilepsy. These findings suggest that stimulation within the ANT subregions adjacent to the MTT improves outcomes.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ilyas A, Snyder KM, Thomas TM, et al. Optimal targeting of the anterior nucleus of the thalamus for epilepsy: a meta-analysis. J Neurosurg. 2022. PMID: 35395631. doi:10.3171/2022.2.JNS212550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。